| | 
Part, Chapter, Paragraph
1 II, 5. 2. 7| J Public Health 95 (1): 103-108.~WHO Expert Committee (
2 II, 5. 4. 8| Metabolism 2001;14(2), 100-103.~Carinci M, Federici Orsini
3 II, 5. 5. 3| in Cyprus. J Neurol Sci 103:29-36.~Milanov I, Georgiev
4 II, 5. 5. 3| risk. Acta Neurol Scand 103:20-26~Pugliatti M, Sotgiu
5 II, 5. 5. 3| Finland. Acta Neurol Scand 103:153-158.~Sumelahti ML, Tienari
6 II, 5. 5. 3| Sweden. Acta Neurol Scand 103:214-218.~Sundström P, Nyström
7 II, 5. 6. 6| quality of life. Am J Med 103:12S-17S~Cooper C, Atkinson
8 II, 5. 12. 7| Naples, Italy. Public Health 103:385-389.~de la Pena J, Brullet
9 II, 6. 3. 6| years. In 2005, some 15 103 cases were reported by 18
10 II, 9. 1. 1| Gynecol Reprod Biol 2002;103(1):4-13.~Apgar V (1953): A t.
11 II, 9. 1. 1| meta-analysis. Obstet Gynecol 2004;103(3):551-63.~ ~Kramer MS,
12 II, 9. 1. 1| implications. Obstet Gynecol 2004;103(1):128-36.~Luke B, Brown
13 II, 9. 1. 1| artefact? Bjog 2007;114(9):1097-103.~ ~Zeitlin J, Wildman K,
14 II, 9. 3. 1| Social Science & Medicine 62 103–115~ ~Association of European
15 II, 9. 3. 2| Gynecol Reprod Biol 2002;103(1):4-13.~ ~Ananth CV, Joseph
16 II, 9. 3. 2| meta-analysis. Obstet Gynecol 2004;103(3):551-63.~ ~Kahn B, Lumey
17 II, 9. 3. 2| implications. Obstet Gynecol 2004;103(1):128-36.~ ~London: Stationery
18 II, 9. 3. 2| artefact? Bjog 2007;114(9):1097-103.~ ~Zeitlin J, Wildman K,
19 II, 9. 4. 7| Age and Ageing. vol. 35, 103-105.~ ~Rathmann W, Haastert
20 III, 10. 2. 1| Public Health Vol. 14(2):103-109.~ ~Greyling T et al. (
21 IV, 11. 6. 5| index." Health Economics 11: 103-115.~ ~Wagstaff A, van Doorslaer
22 IV, 12. 10 | Ministerial Decision 37411/1829/E 103 defining the relevant bodies,
|
|
| |
